组别 | UCLA | ASES | CMS | VAS | ||||
治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | |
观察组(n = 30) | 11.23 ± 2.32 | 32.11 ± 3.19 | 51.12 ± 5.24 | 92.13 ± 4.21 | 50.13 ± 4.67 | 88.32 ± 5.41 | 7.01 ± 2.41 | 1.21 ± 0.32 |
对照组(n = 30) | 11.27 ± 2.43 | 25.73 ± 3.18 | 51.09 ± 5.17 | 82.24 ± 5.85 | 50.14 ± 4.62 | 80.27 ± 5.34 | 6.98 ± 2.36 | 3.75 ± 0.86 |
t | 0.06 | 7.75 | 0.02 | 7.51 | 0.008 | 5.80 | 0.04 | 15.16 |
p | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 | >0.05 | <0.05 |